Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000278035 | SCV000342034 | uncertain significance | not provided | 2016-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087385 | SCV001118346 | likely benign | Glucose-6-phosphate transport defect | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003165758 | SCV003913667 | likely benign | Inborn genetic diseases | 2023-02-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000278035 | SCV001932296 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000278035 | SCV001967463 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004752830 | SCV005344749 | likely benign | SLC37A4-related disorder | 2024-09-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |